Home > Management Dialogue
Kerem Durdag Biovation II LLC

Kerem Durdag
CEO , Biovation II LLC

Since you believe in providing unique solutions to customers based on their applications, what kind of demands do you have and from which markets?
Kerem Durdag
The demands placed on us have several common themes, among which are:

a. There are no performance concessions; the marketplace is focused, savvy and detail oriented.

b. Pricing is always an issue. However, today's markets couple pricing with a demand to be educated about product design, test results and value proposition. This desire for education places another burden on the manufacturer that cannot be minimised.

c. It is a global marketplace; the product fundamentals are common to all but geographic regions have unique and individualised needs that can't be glossed over.

d. Logistics are one of the key delivery determinants; product delivery and support on a global basis affects decision making at the highest levels.

e. The necessity of creating local partnerships and sales channels has resulted in a vibrant eco-system of cooperation and calibration all contextualised within cultural calibrations.
Infection and pathogen control technology is your area of expertise. Can you tell us about the new or upcoming formulations and chemistries Biovation is working towards?
Kerem Durdag
We are focused on our cost-effective but equally efficacious and high performance solutions for advanced wound-care which is predominantly targeted at markets where price sensitivity is high but the market is large and there are strong purchasing drivers. Additionally, the nonwoven materials we have developed that act as a barrier against hospital acquired infections are being channelled to the end customers. We are focused on chemistries that continue to be more natural and "green" for our next generation products.
What is your budget allocated towards research and development?
Kerem Durdag
I think it is safe to say that we expend a fair amount of our budget ensuring a steady pipeline of products for our customers and the marketplace. The nonwoven industry has a strong tradition of R&D and we aim to contribute to that.
What innovations can we expect from Biovation?
Kerem Durdag
Near future activities are in terms of wipe and packaging materials. We aim to commercialise and bring to market once the appropriate and detailed validation and customer testing is completed.
1  2 
View comments on this interview Published on : 30 Dec 2015
Print Interview   |   Forward Link to friend   |   Bookmark and Share
Name Company
Designation Email
Country Phone/Mobile
Character Left:

Note : www.technicaltextile.net/ will publish as many comments as possible but cannot guarantee publication of all. www.technicaltextile.net/ also holds all rights reserved to omit/edit/upload the comments for reasons of clarity, brevity and morality.

Featured Partner

Marcel Alberts Marcel Alberts
Managing Director

Coating at a fibre level is a practice not usually seen in the high-performance fibres industry, des ...
Suresh Patel Suresh Patel
Managing Director
Sidwin Fabric

Sidwin Fabric is a manufacturer and exporter of polypropylene textiles and a wide range of nonwoven ...
Lynda Kelly Lynda Kelly
Senior Vice President
Suominen Corporation

Suominen Corporation is a manufacturer of nonwovens as roll goods for wipes and for hygiene products ...
Kevin Nelson Kevin Nelson
Chief Scientific Officer

Kevin Nelson, Chief Scientific Officer, TissueGen discusses the growing potential of biodegrable fib ...
Urs Stalder Urs Stalder
Sanitized AG

Urs Stalder, CEO, Sanitized AG, talks about the increasing use of hygiene functions in textile produ ...

Esteemed Clients

Everything is about to change. Stay Tuned !